Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop?

Standard

Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop? / Kaesmacher, Johannes; Ospel, Johanna M; Meinel, Thomas R; Boulouis, Grégoire; Goyal, Mayank; Campbell, Bruce C V; Fiehler, Jens; Gralla, Jan; Fischer, Urs.

In: STROKE, Vol. 51, No. 11, 11.2020, p. 3461-3471.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kaesmacher, J, Ospel, JM, Meinel, TR, Boulouis, G, Goyal, M, Campbell, BCV, Fiehler, J, Gralla, J & Fischer, U 2020, 'Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop?', STROKE, vol. 51, no. 11, pp. 3461-3471. https://doi.org/10.1161/STROKEAHA.120.030157

APA

Kaesmacher, J., Ospel, J. M., Meinel, T. R., Boulouis, G., Goyal, M., Campbell, B. C. V., Fiehler, J., Gralla, J., & Fischer, U. (2020). Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop? STROKE, 51(11), 3461-3471. https://doi.org/10.1161/STROKEAHA.120.030157

Vancouver

Kaesmacher J, Ospel JM, Meinel TR, Boulouis G, Goyal M, Campbell BCV et al. Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop? STROKE. 2020 Nov;51(11):3461-3471. https://doi.org/10.1161/STROKEAHA.120.030157

Bibtex

@article{f911a84f9ce64759ad1fc0b703f6c2af,
title = "Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop?",
abstract = "In patients undergoing mechanical thrombectomy, achieving complete (Thrombolysis in Cerebral Infarction 3) rather than incomplete successful reperfusion (Thrombolysis in Cerebral Infarction 2b) is associated with better functional outcome. Despite technical improvements, incomplete reperfusion remains the final angiographic result in 40% of patients according to recent trials. As most incomplete reperfusions are caused by distal vessel occlusions, they are potentially amenable to rescue strategies. While observational data suggest a net benefit of up to 20% in functional independence of incomplete versus complete reperfusions, the net benefit of secondary improvement from Thrombolysis in Cerebral Infarction 2b to 3 reperfusion might differ due to lengthier procedures and delayed reperfusion. Current strategies to tackle distal vessel occlusions consist of distal (microcatheter) aspiration, small adjustable stent retrievers, and administration of intra-arterial thrombolytics. While there are promising reports evaluating those techniques, all available studies show relevant limitations in terms of selection bias, single-center design, or nonconsecutive patient inclusion. Besides an assessment of risks associated with rescue maneuvers, we advocate that the decision-making process should also include a consideration of potential outcomes if complete reperfusion would successfully be achieved. These include (1) a futile angiographic improvement (hypoperfused territory is already infarcted), (2) an unnecessary angiographic improvement (the patient would not have developed infarction if no rescue maneuver was performed), and (3) a successful rescue maneuver with clinical benefit. Currently there is paucity of data on how these scenarios can be predicted and the decision whether to treat or to stop in a patient with incomplete reperfusion involves many unknowns. To advance the status quo, we outline current knowledge gaps and avenues of potential research regarding this clinically important question.",
author = "Johannes Kaesmacher and Ospel, {Johanna M} and Meinel, {Thomas R} and Gr{\'e}goire Boulouis and Mayank Goyal and Campbell, {Bruce C V} and Jens Fiehler and Jan Gralla and Urs Fischer",
year = "2020",
month = nov,
doi = "10.1161/STROKEAHA.120.030157",
language = "English",
volume = "51",
pages = "3461--3471",
journal = "STROKE",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

RIS

TY - JOUR

T1 - Thrombolysis in Cerebral Infarction 2b Reperfusions: To Treat or to Stop?

AU - Kaesmacher, Johannes

AU - Ospel, Johanna M

AU - Meinel, Thomas R

AU - Boulouis, Grégoire

AU - Goyal, Mayank

AU - Campbell, Bruce C V

AU - Fiehler, Jens

AU - Gralla, Jan

AU - Fischer, Urs

PY - 2020/11

Y1 - 2020/11

N2 - In patients undergoing mechanical thrombectomy, achieving complete (Thrombolysis in Cerebral Infarction 3) rather than incomplete successful reperfusion (Thrombolysis in Cerebral Infarction 2b) is associated with better functional outcome. Despite technical improvements, incomplete reperfusion remains the final angiographic result in 40% of patients according to recent trials. As most incomplete reperfusions are caused by distal vessel occlusions, they are potentially amenable to rescue strategies. While observational data suggest a net benefit of up to 20% in functional independence of incomplete versus complete reperfusions, the net benefit of secondary improvement from Thrombolysis in Cerebral Infarction 2b to 3 reperfusion might differ due to lengthier procedures and delayed reperfusion. Current strategies to tackle distal vessel occlusions consist of distal (microcatheter) aspiration, small adjustable stent retrievers, and administration of intra-arterial thrombolytics. While there are promising reports evaluating those techniques, all available studies show relevant limitations in terms of selection bias, single-center design, or nonconsecutive patient inclusion. Besides an assessment of risks associated with rescue maneuvers, we advocate that the decision-making process should also include a consideration of potential outcomes if complete reperfusion would successfully be achieved. These include (1) a futile angiographic improvement (hypoperfused territory is already infarcted), (2) an unnecessary angiographic improvement (the patient would not have developed infarction if no rescue maneuver was performed), and (3) a successful rescue maneuver with clinical benefit. Currently there is paucity of data on how these scenarios can be predicted and the decision whether to treat or to stop in a patient with incomplete reperfusion involves many unknowns. To advance the status quo, we outline current knowledge gaps and avenues of potential research regarding this clinically important question.

AB - In patients undergoing mechanical thrombectomy, achieving complete (Thrombolysis in Cerebral Infarction 3) rather than incomplete successful reperfusion (Thrombolysis in Cerebral Infarction 2b) is associated with better functional outcome. Despite technical improvements, incomplete reperfusion remains the final angiographic result in 40% of patients according to recent trials. As most incomplete reperfusions are caused by distal vessel occlusions, they are potentially amenable to rescue strategies. While observational data suggest a net benefit of up to 20% in functional independence of incomplete versus complete reperfusions, the net benefit of secondary improvement from Thrombolysis in Cerebral Infarction 2b to 3 reperfusion might differ due to lengthier procedures and delayed reperfusion. Current strategies to tackle distal vessel occlusions consist of distal (microcatheter) aspiration, small adjustable stent retrievers, and administration of intra-arterial thrombolytics. While there are promising reports evaluating those techniques, all available studies show relevant limitations in terms of selection bias, single-center design, or nonconsecutive patient inclusion. Besides an assessment of risks associated with rescue maneuvers, we advocate that the decision-making process should also include a consideration of potential outcomes if complete reperfusion would successfully be achieved. These include (1) a futile angiographic improvement (hypoperfused territory is already infarcted), (2) an unnecessary angiographic improvement (the patient would not have developed infarction if no rescue maneuver was performed), and (3) a successful rescue maneuver with clinical benefit. Currently there is paucity of data on how these scenarios can be predicted and the decision whether to treat or to stop in a patient with incomplete reperfusion involves many unknowns. To advance the status quo, we outline current knowledge gaps and avenues of potential research regarding this clinically important question.

U2 - 10.1161/STROKEAHA.120.030157

DO - 10.1161/STROKEAHA.120.030157

M3 - SCORING: Journal article

C2 - 32993461

VL - 51

SP - 3461

EP - 3471

JO - STROKE

JF - STROKE

SN - 0039-2499

IS - 11

ER -